Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Differing trends in the incidence of vascular comorbidity in MS and the general population.
[The overall assessment of the quality of the physical health of patients with multiple sclerosis after the application of physical therapy. Part 1].
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Thrombotic microangiopathy due to acquired ADAMTS13 deficiency in a patient receiving interferon-beta treatment for multiple sclerosis.
Tumefactive multiple sclerosis presenting with tonic-clonic seizure.
A dual concurrent mechanism explains trigeminal neuralgia in patients with multiple sclerosis.
195 How Well Do Neuroradiologists Predict the Side of Trigeminal Neuralgia?
Prevalence of Multiple Sclerosis in the Republic of Moldova.
Plasma ubiquitin?proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
The use of cytokine signature patterns: separating drug naïve, interferon and natalizumab-treated multiple sclerosis patients.
Implications of Real-world Adherence on Cost-effectiveness Analysis in Multiple Sclerosis.
Clinical relevance of brain atrophy assessment in multiple sclerosis. Implications for its use in a clinical routine.
Brain-gut axis and pentadecapeptide BPC 157. Theoretical and practical implications.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Vitamin D3 transactivates the zinc and manganese transporter SLC30A10 via the Vitamin D receptor.
Alpha/beta interferon is a neuronal growth factor.
PiB and other amyloid-PET tracers for the study of white matter and multiple sclerosis.
Autoantibodies and pain.
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US Patients.
Multiple Sclerosis: An Update.
Urinary incontinence in multiple sclerosis: prevalence, severity and impact on patients' quality of life.
Interrater Reliability of Four Sensory Measures in People with Multiple Sclerosis.
Multiple sclerosis and risk of attempted and completed suicide - a cohort study.
Multimodal quantitative MRI assessment of cortical damage in relapsing-remitting multiple sclerosis.
Oral Dimethyl Fumarate in Children With Multiple Sclerosis: A Dual-Center Study.
Pages
« first
‹ previous
…
29
30
31
32
33
34
35
36
37
…
next ›
last »